Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) — Form 8-K: Current report
About this filing
Syndax Pharmaceuticals, Inc. (SNDX) filed an 8-K on Jul 14, 2026 reporting other events (Item 8.01), with exhibits (Item 9.01).
Key facts
- Item 8.01 · Other events
- Item 9.01 · Financial statements and exhibits
More SNDX filings
- 4
Filed Oct 30, 2026
- 144
Filed Oct 29, 2026
- SC 13G
Filed Aug 7, 2026
- 10-Q
Filed Aug 4, 2026
- 8-K
Filed Aug 4, 2026
- 4
Filed Jul 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.